Surface Oncology (SURF) Short Interest Ratio & Short Volume → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free SURF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Surface Oncology Short Interest DataCurrent Short Volume165,300 sharesPrevious Short Volume236,900 sharesChange Vs. Previous Month-30.22%Dollar Volume Sold Short$150,918.90Short Interest Ratio / Days to Cover0.2Last Record DateAugust 15, 2023Outstanding Shares60,824,000 sharesPercentage of Shares Shorted0.27%Today's Trading Volume1,510,100 sharesAverage Trading Volume430,375 sharesToday's Volume Vs. Average351% Short Selling Surface Oncology ? Sign up to receive the latest short interest report for Surface Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSURF Short Interest Over TimeSURF Days to Cover Over TimeSURF Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Surface Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2023165,300 shares $150,918.90 -30.2%N/A0.2 $0.91 7/31/2023236,900 shares $229,816.69 -16.7%N/A0.3 $0.97 7/15/2023284,500 shares $259,321.75 -36.6%N/A0.4 $0.91 6/30/2023448,400 shares $389,928.64 -44.6%N/A0.7 $0.87 6/15/2023809,000 shares $598,660.00 -11.4%N/A1.3 $0.74 5/31/2023913,500 shares $717,188.85 +1.0%N/A4.4 $0.79 Get the Latest News and Ratings for SURF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Surface Oncology and its competitors with MarketBeat's FREE daily newsletter. 5/15/2023904,600 shares $565,555.92 +6.7%N/A4.3 $0.63 4/30/2023847,700 shares $487,512.27 +2.3%N/A4.4 $0.58 4/15/2023828,500 shares $571,665.00 -8.2%N/A4 $0.69 3/31/2023902,100 shares $630,387.48 -9.2%N/A4.2 $0.70 3/15/2023993,300 shares $680,708.49 +17.6%N/A3.9 $0.69 2/28/2023844,400 shares $557,304.00 +17.7%N/A3 $0.66 2/15/2023717,700 shares $587,796.30 +4.3%N/A2.5 $0.82 1/31/2023688,200 shares $642,916.44 -25.9%N/A2.3 $0.93 1/15/2023928,100 shares $918,819.00 +5.7%N/A2.6 $0.99 12/30/2022877,900 shares $719,878.00 -3.4%N/A2.5 $0.82 12/15/2022909,100 shares $724,552.70 -10.9%N/A2.7 $0.80 11/30/20221,020,000 shares $938,400.00 -11.3%N/A3.1 $0.92 11/15/20221,150,000 shares $1.31 million -17.3%N/A3.1 $1.14 10/31/20221,390,000 shares $1.72 million -4.1%N/A3 $1.24 10/15/20221,450,000 shares $1.51 million -12.1%N/A3 $1.04 9/30/20221,650,000 shares $1.72 million +7.8%N/A3.2 $1.04 9/15/20221,530,000 shares $2.00 million +4.8%N/A2.3 $1.31 8/31/20221,460,000 shares $1.99 million -2.0%N/A2 $1.36 8/15/20221,490,000 shares $2.92 million -11.8%N/A1.9 $1.96 7/31/20221,690,000 shares $2.89 million -29.6%N/A2.2 $1.71 7/15/20222,400,000 shares $4.66 million +47.2%N/A3 $1.94 6/30/20221,630,000 shares $2.67 million -34.3%N/A2 $1.64 6/15/20222,480,000 shares $3.79 million -11.1%N/A3.2 $1.53 5/31/20222,790,000 shares $5.16 million +9.4%N/A3.5 $1.85 5/15/20222,550,000 shares $5.00 million -3.8%N/A3.4 $1.96 4/30/20222,650,000 shares $5.62 million +27.4%7.1%3.7 $2.12 4/15/20222,080,000 shares $5.30 million +11.8%5.6%3.1 $2.55 3/31/20221,860,000 shares $5.47 million +1.1%5.0%2.8 $2.94 3/15/20221,840,000 shares $4.97 million -13.2%5.0%2.7 $2.70 2/28/20222,120,000 shares $7.63 million -2.3%5.7%3.6 $3.60 2/15/20222,170,000 shares $8.05 million -4.0%5.9%3.7 $3.71 1/31/20222,260,000 shares $8.48 million +4.2%6.0%3.8 $3.75 1/15/20222,170,000 shares $9.33 million +10.7%5.8%3.8 $4.30 12/31/20211,960,000 shares $9.37 million -12.1%5.2%3.4 $4.78Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. SURF Short Interest - Frequently Asked Questions What is Surface Oncology's current short interest? Short interest is the volume of Surface Oncology shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 165,300 shares of SURF short. Learn More on Surface Oncology's current short interest. Is Surface Oncology's short interest increasing or decreasing? Surface Oncology saw a drop in short interest during the month of August. As of August 15th, there was short interest totaling 165,300 shares, a drop of 30.2% from the previous total of 236,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Surface Oncology's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Surface Oncology: LianBio (0.36%), Kinnate Biopharma Inc. (2.01%), NGM Biopharmaceuticals, Inc. (4.52%), Ikena Oncology, Inc. (5.48%), MediciNova, Inc. (0.53%), Rallybio Co. (17.17%), Pro-Dex, Inc. (0.91%), Genenta Science S.p.A. (0.02%), Entera Bio Ltd. (0.31%), Aligos Therapeutics, Inc. (0.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.78 billion), Occidental Petroleum Co. ($3.04 billion), Royal Caribbean Cruises Ltd. ($2.10 billion), Celsius Holdings, Inc. ($1.98 billion), Coinbase Global, Inc. ($1.97 billion), T. Rowe Price Group, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.83 billion), Tractor Supply ($1.82 billion), Moderna, Inc. ($1.66 billion), and CarMax, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Surface Oncology stock? Short selling SURF is an investing strategy that aims to generate trading profit from Surface Oncology as its price is falling. SURF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Surface Oncology? A short squeeze for Surface Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SURF, which in turn drives the price of the stock up even further. How often is Surface Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SURF, twice per month. The most recent reporting period available is August, 15 2023. More Short Interest Resources from MarketBeat Related Companies: LianBio Short Interest Kinnate Biopharma Short Interest NGM Biopharmaceuticals Short Interest Ikena Oncology Short Interest MediciNova Short Interest Rallybio Short Interest Pro-Dex Short Interest Genenta Science Short Interest Entera Bio Short Interest Aligos Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SURF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold